FOR IMMEDIATE RELEASE
Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand Masterclass
Bangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.

Clinical Excellence Backed by Data
According to Singderm’s official brochure:
92.7% efficacy at 12 months measured by Wrinkle Severity Rating Scale (WSRS)
Median pain score of 2.0 (0-10 scale) in independent assessments
100% nodule-free results across 3 injection sites (China, Italy, Brazil)
Dr. Worawat Nolah emphasized:
"Singderm’s 24mg/mL HA concentration and SingLink™ cross-linking technology deliver unmatched stability – crucial for natural outcomes in dynamic areas like lips and nasolabial folds."
KOLs Verify Real-World Performance
ChalidaornPinNy on longevity:
"No lumps or migration after 6 months – exactly as the brochure promises!"HackAnantaya on comfort:
"The BD Hylok™ syringe made injections seamless – I felt only mild pressure."ThantayaThuranuch on versatility:
"From under-eyes to temples, Singderm held shape identically."
Why Singderm Stands Apart
Patented Technology
SingLink™ Cross-Linking : Ensures 12-month durability
StabilityTech™ Formula : Prevents migration in mobile zones
Safety Assurance
Non-Animal HA (Streptococcus fermentation, JP/EP certified)
Terminal Sterilization at 121°C
Enhanced Experience
BD Hylok™ Prefilled Syringe with integrated Luer Lock
0.3% Lidocaine for minimized pain
Global Compliance & Availability
Certified under CE 2292, NMPA, and ISO 13485, Singderm is available worldwide via distributors like SingdermThailand. As stated by Dr. Lucia Linde
"Perfect for plumping lips and full-face rejuvenation – I love this product!"
-
singclean | 2025-08-19
2026 Global Dermal Filler Trend Outlook:As the global medical aesthetics market continues to evolve, consumer and clinician demands for dermal fillers are undergoing an unprecedented paradigm shift. From the early days of "blind filling and chasing volume" to today's focus on "anatomical refinement, natural facial dynamics, and ultimate comfort," the industry has officially entered the Hyaluronic Acid 4.0 Era. In this transformation driven by safety, comfort, longevity, and natural results, innovative Chinese brands like Singderm® are accelerating their breakthrough into the premium global aesthetics landscape, powered by proprietary technologies and rigorous international standards. -
singclean | 2025-08-19
Dual-Exhibition Global Layout! Singclean Medical to Showcase Premium Biomaterials and IVD Innovations at WHX Miami & WHX Bangkok 2026With the rapid advancement and technical iteration of the global healthcare industry, international presence has become the core engine for the sustainable growth of leading medical device enterprises. Hangzhou Singclean Medical Products Co., Ltd. (Singclean Medical), a globally recognized leader in medical biomaterials and In Vitro Diagnostics (IVD), has announced its upcoming participation in two world-class healthcare exhibitions from June to July 2026: WHX Miami (World Health Expo Miami 2026) in the United States and WHX Bangkok (World Health Expo Bangkok 2026) in Thailand. Singclean Medical will seize these opportunities to demonstrate its latest achievements under the dual-wheel drive of "Medical Biomaterials" and "In Vitro Diagnostics," cordially inviting global partners to explore new horizons in medical healthcare. -
singclean | 2025-08-19
Singclean Medical Shines at Mevos 2026 with Two New Singfiller Products, Ushering in a New Decade of Precision Filling